1. Exploratory Factor Analysis for Validating Traditional Chinese Syndrome Patterns of Chronic Atrophic Gastritis
   Yin Zhang et al, 2016, Evidence-Based Complementary and Alternative Medicine CrossRef
2. Status of Epstein-Barr Virus Coinfection with Helicobacter pylori in Gastric Cancer
   Shyam Singh et al, 2017, Journal of Oncology CrossRef
3. Comparative Evaluation of RUT, PCR and ELISA Tests for Detection of Infection with Cytotoxigenic H. pylori
   Farzaneh Jalalypour et al, 2016, Adv Pharm Bull CrossRef
4. The Utilization of a New Immunochromatographic Test in Detection ofHelicobacter pyloriAntibody from Maternal and Umbilical Cord Serum
   Fu-Chen Kuo et al, 2014, BioMed Research International CrossRef
5. Omega-3 Polyunsaturated Fatty Acids Intake to RegulateHelicobacter pylori-Associated Gastric Diseases as Nonantimicrobial Dietary Approach
   Jong-Min Park et al, 2015, BioMed Research International CrossRef
6. Correlation between CD34 Marker and Clinico-Pathologic Characteristics of Gastric Cancer
   Afshin Habibi et al, 2015, International J. of Cancer Research CrossRef
7. Role of Chlamydia in the Development of Ocular Adnexal Lymphoma
   Carlo Contini et al, 2013, JCT CrossRef
8. Increased expression of argininosuccinate synthetase protein predicts poor prognosis in human gastric cancer
   YAN-SHEN SHAN et al, 2015 CrossRef
9. Gastric cancer: Metabolic and metabolomics perspectives (Review).
   Shiyu Xiao et al, 2017, Int J Oncol CrossRef
10. Helicobacter pylori promotes VEGF expression via the p38 MAPK-mediated COX-2-PGE2 pathway in MKN45 cells
    NINGNING LIU et al, 2014 CrossRef
11. Precancerous colorectal lesions (Review).
    Vincenza Conteduca et al, 2013, Int J Oncol CrossRef
12. Correlation between virulence markers of Helicobacter pylori in the oral cavity and gastric biopsies
    Myriam Lucrecia MEDINA et al, 2017, Arq. Gastroenterol. CrossRef
13. MicroRNAs as potential biomarkers for gastric cancer
    Han-Shao Liu, 2014, WJG CrossRef
14. SerumHelicobacter pyloriKatA and AhpC antibodies as novel biomarkers for gastric cancer
    Bing Zhang et al, 2016, WJG CrossRef
15. Inflammatory microenvironment contributes to epithelial-mesenchymal transition in gastric cancer
    Hui-Ying Ma et al, 2016, WJG CrossRef
16. Recurrence of infection and diversity of Helicobacter pylori strains in an adult population in Mexico treated with empirical standard triple therapy.
    Jaime Alberto Sánchez Cuén et al, 2017, Rev Esp Enferm Dig CrossRef
17. High TREM2 expression correlates with poor prognosis in gastric cancer
    Xiaojing Zhang et al, 2017, Human Pathology CrossRef
18. Propolis: The future therapy against Helicobacter pylori -mediated gastrointestinal diseases
    Ummay Mahfuza Shapla et al, 2017, Journal of Applied Biomedicine CrossRef
19. Role of phytochemicals in the inhibition of epithelial–mesenchymal transition in cancer metastasis
    Eun-Kyung Kim et al, 2016, Food Funct. CrossRef
20. Antimetastatic Effects of Celastrus orbiculatus on Human Gastric Adenocarcinoma by Inhibiting Epithelial–Mesenchymal Transition and NF-κB/Snail Signaling Pathway
    Yaodong Zhu et al, 2015, Integr Cancer Ther CrossRef
21. Molecular dysexpression in gastric cancer revealed by integrated analysis of transcriptome data
    Xiaomei Li et al, 2017 CrossRef
22. Inside Helicobacter Pylori: A Serious Threat to Humans
    Abdul Rehman, 2018, Avicenna J Clin Microb Infec CrossRef
23. Unusual presentation of duodenal plasmablastic lymphoma in an immunocompetent patient: A case report and literature review
    CHUN CAO et al, 2014 CrossRef
24. Expression of early growth response gene-1 in precancerous lesions of gastric cancer.
    Seon-Young Park et al, 2016, Oncol Lett CrossRef
25. Levels of malondialdehyde in the gastric juice: Its association with Helicobacter pylori infection and stomach diseases
    Yao-Kuang Wang et al, 2018, Helicobacter CrossRef
26. Preliminary opinion on assessment categories of stomach ultrasound report and data system (Su-RADS)
    Zhining Liu et al, 2018, Gastric Cancer CrossRef
27. Plasma exosomes as novel biomarker for the early diagnosis of gastric cancer
    Jianjun Wang et al, 2018, CBM CrossRef
28. Incidence of gastric cancer in the USA during 1999 to 2013: a 50-state analysis
    Zhensheng Wang et al, 2018 CrossRef
29. Global estimate of gastric cancer in Helicobacter pylori -infected population: A systematic review and meta-analysis
    Ali Pormohammad et al, 2018, J Cell Physiol CrossRef
30. Predictive Factors for Improvement of Atrophic Gastritis and Intestinal Metaplasia: A Long-term Prospective Clinical Study
    Young-Jae Hwang et al, 2018, Korean J Helicobacter Up Gastrointest Res CrossRef
31. Üst gastrointestinal sistem endoskopisi yapılan hastalarda intestinal metaplazi ve Helikobakter pylori skorlarının karşılaştırılması
    Uğur Kesici, 2018 CrossRef
32. Protein changes in gastric epithelial cells RGM-1 in response to Helicobacter pylori infection
    Zengfa Lv et al, 2018, J Cell Biochem CrossRef
33. Interleukin-6 Expression in Serum, Gastric Juice and Gastric Mucosa of Helicobacter pylori Positive Gastric Cancer Patients
    Yanglong Chen et al, 2019, International J. of Pharmacology CrossRef
34. Long-term gastric cancer risk in male smokers with atrophic corpus gastritis
    Anna A. Nieminen et al, 2019, Scandinavian Journal of Gastroenterology CrossRef
35. Correlation between macrophage migration inhibitory factor and autophagy in Helicobacter pylori-associated gastric carcinogenesis
    Kichul Yoon et al, 2019, PLoS ONE CrossRef
36. Gastric Microbiota in Helicobacter pylori-Negative and -Positive Gastritis Among High Incidence of Gastric Cancer Area
    Boldbaatar Gantuya et al, 2019, Cancers CrossRef
37. Composite protective lifestyle factors and risk of developing gastric adenocarcinoma: the Singapore Chinese Health Study
    Zhensheng Wang et al, 2017, Br J Cancer CrossRef
38. Gastric cancer-molecular and clinical dimensions.
    Roopma Wadhwa et al, 2013, Nat Rev Clin Oncol CrossRef
39. Serum Helicobacter pylori NapA antibody as a potential biomarker for gastric cancer
    Jingjing Liu et al, 2015, Sci Rep CrossRef
40. Helicobacter pylori Genetic Diversity and Gastro-duodenal Diseases in Malaysia
    Selva Perumal Gunaletchumy et al, 2015, Sci Rep CrossRef
41. Exosomes as nanocarriers for systemic delivery of the Helicobacter pylori virulence factor CagA
    Asako Shimoda et al, 2016, Sci Rep CrossRef
42. Pathogenesis of Esophageal Cancer
    Charles LeVea, 2015 CrossRef
43. The irreversible HCV-associated risk of gastric cancer following interferon-based therapy: a joint study of hospital-based cases and nationwide population-based cohorts
    Chun-Wei Chen et al, 2019, Therap Adv Gastroenterol CrossRef
44. Salt-mediated transcriptional and proteasomal dysregulations mimic the molecular dysregulations of stomach cancer
    Karthik Balakrishnan et al, 2019, Toxicology in Vitro CrossRef
45. Corticotropin Releasing Hormone Is Correlated With Tumorigenesis of Gastric Cancer
    Shaobo Yang et al, 2013, Cancer Investigation CrossRef
46. Risk assessment models of integrative medicine indicators for malignant transformation of chronic atrophic gastritis: A registry study protocol
    Yue Liu et al, 2019, Journal of Traditional Chinese Medical Sciences CrossRef
47. Exophytic primary gastric squamous cell carcinoma and H. pylori gastritis
    Kehua Zhou et al, 2019, BMJ Case Rep CrossRef
48. Helicobacter pylori and the gastric microbiota
    Lars Engstrand et al, 2013, Best Practice & Research Clinical Gastroenterology CrossRef
49. Recent developments in esophageal adenocarcinoma.
    Jesper Lagergren et al, 2013, CA Cancer J Clin CrossRef
50. Helicobacter pylori-Induced Chronic Gastritis and Assessing Risks for Gastric Cancer
    Gonzalo Carrasco et al, 2013, Gastroenterology Research and Practice CrossRef
51. Gastric cancer in patients with gastric atrophy and intestinal metaplasia: A systematic review and meta-analysis
    Maryam Akbari et al, 2019, PLoS ONE CrossRef
52. Managing the changing burden of cancer in Asia
    Rengaswamy Sankaranarayanan et al, 2014, BMC Med CrossRef
53. The Influence of Microbial Metabolites in the Gastrointestinal Microenvironment on Anticancer Immunity
    Silke Neumann et al, 2019 CrossRef
54. Seguimiento de las lesiones displásicas o premalignas del tubo digestivo
    Laura Carot Bastard et al, 2014, FMC - Formación Médica Continuada en Atención Primaria CrossRef
55. Gastric mucin expression in first-degree relatives of gastric cancer patients
    Doron Boltin et al, 2014, European Journal of Gastroenterology & Hepatology CrossRef
56. Risk of Malignancy Associated with a Maternal Family History of Cancer
    Ju Liu et al, 2014, Asian Pacific Journal of Cancer Prevention CrossRef
57. Research on the efficacy of Celastrus Orbiculatus in suppressing TGF-β1-induced epithelial-mesenchymal transition by inhibiting HSP27 and TNF-α-induced NF-κB/Snail signaling pathway in human gastric adenocarcinoma
    Yaodong Zhu et al, 2014, BMC Complement Altern Med CrossRef
58. Extracts of Celastrus orbiculatus exhibit anti-proliferative and anti-invasive effects on human gastric adenocarcinoma cells
    Yao-dong Zhu et al, 2014, Chin. J. Integr. Med. CrossRef
59. Biological evaluation and molecular docking of baicalin and scutellarin as Helicobacter pylori urease inhibitors
    Xiao-Dan Yu et al, 2015, Journal of Ethnopharmacology CrossRef
60. Human Microbiome: When a Friend Becomes an Enemy
    Magdalena Muszer et al, 2015, Arch. Immunol. Ther. Exp. CrossRef
61. Helicobacter pylori Uses the TlpB Receptor To Sense Sites of Gastric Injury
    Hikaru Hanyu et al, 2019, Infect Immun CrossRef
62. A meta-analysis: The association between interleukin-17 pathway gene polymorphism and gastrointestinal diseases
    Yu-Xing Jiang et al, 2015, Gene CrossRef
63. Cyclooxigenase-2 and osteopontin in gastric pre-neoplastic lesions in relation to H-pylori infection and grade of inflammation
    Inés Benedetti et al, 2019, Revista Española de Patología CrossRef
64. Prediction of the 10-year probability of gastric cancer occurrence in the Japanese population: the JPHC study cohort II
    Hadrien Charvat et al, 2016, Int. J. Cancer CrossRef
65. Genetic and epigenetic alterations of netrin-1 receptors in gastric cancer with chromosomal instability
    Keisuke Toda et al, 2015, Clin Epigenet CrossRef
66. Positive relationship betweenp42.3gene and inflammation in chronic non-atrophic gastritis
    Ping Chen et al, 2015, Journal of Digestive Diseases CrossRef
67. The distribution of jhp0940, jhp0945, jhp0947, jhp0949 and jhp0951 genes of Helicobacter pylori in China
    Yanan Gong et al, 2015, BMC Gastroenterol CrossRef
68. Estimation of Cancer Burden Attributable to Infection in Asia
    He Huang et al, 2015, Journal of Epidemiology CrossRef
69. Human gastric cancer, Helicobacter pylori and bracken carcinogens: A connecting hypothesis
    Alberto Oliveros-Bastidas et al, 2016, Medical Hypotheses CrossRef
70. Helicobacter pylori, Experimental Autoimmune Encephalomyelitis, and Multiple Sclerosis
    Karen Robinson et al, 2016 CrossRef
71. Gastric Cancer
    Hyuk Yoon, 2016 CrossRef
72. Binary mixture ofSatureja hortensisandOriganum vulgaresubsp.hirtumessential oils: in vivo therapeutic efficiency againstHelicobacter pyloriinfection
    Maria Harmati et al, 2017, Helicobacter CrossRef
73. C/EBPβ regulates homeostatic and oncogenic gastric cell proliferation.
    Goncalo Regalo et al, 2016, J Mol Med (Berl) CrossRef
74. The Diagnostic Value of Gastrin-17 Detection in Atrophic Gastritis
    Xu Wang et al, 2016, Medicine CrossRef
75. Promising in vitro and in vivo inhibition of multidrug-resistant Helicobacter pylori by linezolid and novel oxazolidinone analogues
    Jingdong Shi et al, 2016, Journal of Global Antimicrobial Resistance CrossRef
76. Regression of gastric intestinal metaplasia after the eradication of Helicobacter pylori infection in a hospital in Mexico
    Jaime Alberto Sánchez Cuén et al, 2016, Rev Esp Enferm Dig CrossRef
77. Differences in amino acid frequency in CagA and VacA sequences of Helicobacter pylori distinguish gastric cancer from gastric MALT lymphoma
    Masahiko Hashinaga et al, 2016, Gut Pathog CrossRef
78. Somatic copy number alterations in gastric adenocarcinomas among Asian and Western patients
    Steven E. Schumacher et al, 2017, PLoS ONE CrossRef
79. Primary Helicobacter pylori resistance in elderly patients over 20 years: A Bulgarian study
    Lyudmila Boyanova et al, 2017, Diagnostic Microbiology and Infectious Disease CrossRef
80. miR-376c promotes carcinogenesis and serves as a plasma marker for gastric carcinoma
    Pei-Shih Hung et al, 2017, PLoS ONE CrossRef
81. The study ofH. pyloriputative candidate factors for single- and multi-component vaccine development
    Nasrin Mirzaei et al, 2017, Critical Reviews in Microbiology CrossRef
82. Association between polymorphisms of thymidylate synthase gene 5′- and 3′-UTR and gastric cancer risk: meta-analysis
    Ao Mo et al, 2016 CrossRef
83. Rapidly declining trend of signet ring cell cancer of the stomach may parallel the infection rate of Helicobacter pylori.
    Hiroshi Ohyama et al, 2019, BMC Gastroenterol CrossRef
84. Association between Helicobacter pylori infection and kidney damage in patients with peptic ulcer
    Wei Pan et al, 2019, Renal Failure CrossRef
85. Helicobacter pylori Infection, Virulence Genes’ Distribution and Accompanying Clinical Outcomes: The West Africa Situation
    Eric Gyamerah Ofori et al, 2019, BioMed Research International CrossRef
86. Metal-induced change in catalytic loop positioning in Helicobacter pylori arginase alters catalytic function
    Ankita Dutta et al, 2019 CrossRef
87. Clinical Outcomes of Metachronous Gastric Cancer after Endoscopic Resection for Early Gastric Cancer
    Jue Lie Kim et al, 2020, Gut and Liver CrossRef
88. Preparation, characterization, and anticancer efficacy of novel cobalt oxide nanoparticles conjugated with thiosemicarbazide
    Mahsa Jarestan et al, 2020, 3 Biotech CrossRef
89. Helicobacter pylori associated factors in the development of gastric cancer with special reference to the early-onset subtype
    Małgorzata Pucułek et al, 2018, Oncotarget CrossRef
90. Serum Helicobacter pylori FliD antibody and the risk of gastric cancer
    Hailin Li et al, 2016, Oncotarget CrossRef
91. Estimation of the performance of a risk prediction model for gastric cancer occurrence in Japan: Evidence from a small external population
    Hadrien Charvat et al, 2020, Cancer Epidemiology CrossRef
92. Helicobacter pylori virulence factors expression affect epigenetic factors leading to gastrointestinal carcinoma
    Al-Alo KZK et al, 2020 CrossRef
93. Inflammatory responses induced by Helicobacter pylori on the carcinogenesis of gastric epithelial GES‑1 cells
    Jianjun Wang et al, 2019, Int J Oncol CrossRef
94. Regulation of GKN1 expression in gastric carcinogenesis: A problem to resolve (Review)
    Judit Alarc�n‑Mill�n et al, 2019, Int J Oncol CrossRef
95. Downregulation of peroxiredoxin II suppresses the proliferation and metastasis of gastric cancer cells.
    Linjun Niu et al, 2018, Oncol Lett CrossRef
96. Curcumin induces expression of 15-hydroxyprostaglandin dehydrogenase in gastric mucosal cells and mouse stomach in vivo: AP-1 as a potential target
    Jeong-Hwa Woo et al, 2020, The Journal of Nutritional Biochemistry CrossRef
97. Anti-inflammatory and anti-oxidative effect of Korean propolis on Helicobacter pylori-induced gastric damage in vitro
    Moon-Young Song et al, 2020, J Microbiol. CrossRef
98. Pathways of Gastric Carcinogenesis, Helicobacter pylori Virulence and Interactions with Antioxidant Systems, Vitamin C and Phytochemicals
    James W. T. Toh et al, 2020, IJMS CrossRef
99. Gastric cancer: a comprehensive review of current and future treatment strategies.
    Rachel E Sexton et al, 2020, Cancer Metastasis Rev CrossRef
100. Gastric Stem Cells: Physiological and Pathological Perspectives
     Shiyu Xiao et al, 2020, Front. Cell Dev. Biol. CrossRef
101. Non-Invasive Early Molecular Detection of Gastric Cancers
     Hiroyuki Yamamoto et al, 2020, Cancers CrossRef
102. PROSPECTIVE COMPARATIVE STUDY OF THE TREATMENT OF HELICOBACTER PYLORI WITH ANTIBIOTIC SUSCEPTIBILITY TESTING-GUIDED TRIPLE THERAPY COMPARED TO QUADRUPLE THERAPY WITH PYLERA�
     Rocío Bonoso Criado et al, 2020, Rev Esp Enferm Dig CrossRef
103. Relationship between MTHFR Gene Polymorphisms and Gastrointestinal Tumors Development: Perspective from Eastern Part of Turkey
     Ersoy Öksüz et al, 2020, Journal of Investigative Surgery CrossRef
104. Predictive Effect of Helicobacter pylori in Gastric Carcinoma Development: Systematic Review and Quantitative Evidence Synthesis
     Laurens Holmes et al, 2021, Medicines CrossRef
105. Cytokine-Mediated Crosstalk between Immune Cells and Epithelial Cells in the Gut
     Mousumi Mahapatro et al, 2021, Cells CrossRef
106. Immuno-Oncology of Colorectal Cancer
     Ramachandra Reddy Pamuru et al, 2020 CrossRef
107. An evolutionary non-conserved motif in Helicobacter pylori arginase mediates positioning of the loop containing the catalytic residue for catalysis
     Ankita Dutta et al, 2021 CrossRef
108. Luteolin and cancer metastasis suppression: focus on the role of epithelial to mesenchymal transition
     Yaseen Hussain et al, 2021, Med Oncol CrossRef
109. Laryngeal Helicobacter pylori Infection and Laryngeal Cancer-Case Series and a Systematic Review
     Li-Jen Hsin et al, 2021, Microorganisms CrossRef
110. Antibiotic resistance pattern and frequency of cagA and vacA genes in Helicobacter pylori strains isolated from patients in Tabriz city, Iran
     Farnaz Rasi-Bonab et al, 2021, BMC Res Notes CrossRef
111. Eremomastax speciosa (Hochst.) Cufod. counteracts the delaying effect of indomethacin on Helicobacter pylori-associated chronic gastric ulcers healing
     Gaël Tchokomeni Siwe et al, 2021, Journal of Ethnopharmacology CrossRef
112. Frequency of virulence-associated genotypes of Helicobacter pylori and their correlation with clinical outcome and histological parameters in infected patients
     Milad Shahini Shams Abadi et al, 2021, Heliyon CrossRef
113. Bacteria-mediated cancer therapies: opportunities and challenges
     Meiyang Yang et al, 2021, Biomater. Sci. CrossRef
114. Development and Validation of Nomograms to Predict Operative Link for Gastritis Assessment Any-Stage and Stages III–IV in the Chinese High-Risk Gastric Cancer Population
     Song Wang et al, 2021, Front. Med. CrossRef
115. Association of Dietary Cholesterol Intake With Risk of Gastric Cancer: A Systematic Review and Meta-Analysis of Observational Studies
     Peng Miao et al, 2021, Front. Nutr. CrossRef
116. Helicobacter pylori virulence factors and host genetic polymorphisms in a low gastric cancer incidence and high H pylori prevalence country
     Colin J. Rush et al, 2021, GastroHep CrossRef
117. Characterization and comparison of bacterial communities in benign vocal fold lesions
     Alissa S Hanshew et al, 2014, Microbiome CrossRef
118. Role of Helicobacter pylori in the triggering and evolution of hemorrhagic gastro‑duodenal lesions
     Dragos Popa et al, 2021, Exp Ther Med CrossRef
119. Glycosaminoglycan biosynthesis pathway in host genome is associated with Helicobacter pylori infection
     Dingxue Hu et al, 2021, Sci Rep CrossRef
120. Infection with a hypervirulent strain of Helicobacter pylori primes gastric cells toward intestinal transdifferentiation
     Samaneh Saberi et al, 2021, Microbial Pathogenesis CrossRef
121. Helicobacter pylori Pathogenicity Islands and Giardia lamblia Cysteine Proteases in Role of Coinfection and Pathogenesis
     Mihret Tilahun et al, 2022, IDR CrossRef
122. Microbiome changes in the gastric mucosa and gastric juice in different histological stages of Helicobacter pylori-negative gastric cancers
     Qing-Hua Sun et al, 2022, WJG CrossRef
123. Prevalence of Helicobacter Pylori Infection in Patients with Dyspepsia in North of Iran
     Seyed Mohammad Valizadeh Toosi et al, 2021, Middle East J Dig Dis CrossRef
124. Comparative genomics analysis of statistically significant genomic islands of Helicobacter pylori strains for better understanding the disease prognosis
     Joyeeta Chakraborty et al, 2022 CrossRef
125. Caracterización del cáncer gástrico en Guatemala
     V.L. Matta de García et al, 2015, Rev.Cient. CrossRef
126. Induction of Fibroblast Growth Factor Receptor 4 by Helicobacter pylori via Signal Transducer and Activator of Transcription 3 With a Feedforward Activation Loop Involving Steroid Receptor Coactivator Signaling in Gastric Cancer
     Xing Zhang et al, 2022, Gastroenterology CrossRef
127. Helicobacter pylori infection: A balance between bacteria and host
     Pamela Bucci et al, 2022, Revista Argentina de Microbiología CrossRef
128. Frequency of Gastrointestinal Diseases Diagnosed on Barium Contrast Studies
     Aneeqa Khalid et al, 2022, PBMJ CrossRef
129. Regulatory function of DNA methylation mediated lncRNAs in gastric cancer
     Nan Li et al, 2022, Cancer Cell Int CrossRef
130. Performance of DNA Methylation on the Molecular Pathogenesis of Helicobacter pylori in Gastric Cancer; targeted therapy approach
     Sogand Vahidi et al, 2022, J Pharmacopuncture CrossRef
131. High serum levels of l-carnitine and citric acid negatively correlated with alkaline phosphatase are detectable in Koreans before gastric cancer onset
     Youngmin Han et al, 2022, Metabolomics CrossRef
132. Alterations in the gastric microbiota and metabolites in gastric cancer: An update review
     Changzhen Lei et al, 2022, Front. Oncol. CrossRef
133. Host Cell Antimicrobial Responses against Helicobacter pylori Infection: From Biological Aspects to Therapeutic Strategies
     Judeng Zeng et al, 2022, IJMS CrossRef
134. Gastric bacteria as potential biomarkers for the diagnosis of atrophic gastritis
     Tianyi Dong et al, 2022, Mol Biol Rep CrossRef
135. Statins and the Risk of Gastric Cancer: A Systematic Review and Meta-Analysis
     Chun-Hsien Su et al, 2022, JCM CrossRef
136. A Wnt-related gene expression signature to improve the prediction of prognosis and tumor microenvironment in gastric cancer
     Shuai Kong et al, 2022, Front. Genet. CrossRef
137. A Rare Case of Metastatic Gastric Signet Ring Cell Adenocarcinoma in a 23-Year-Old Female Presenting as Malignant Pleural Effusion
     Beatrice E Torere et al, 2022 CrossRef
138. Data on differential pathogenic ability of Helicobacter pylori isolated from distinct gastric niches
     Budhadev Baral et al, 2023, Data in Brief CrossRef
139. Cancer-Associated Infectious Agents and Epigenetic Regulation
     Vidya Vedham et al, 2015 CrossRef
140. Effect of Helicobacter pylori Eradication Treatment on Metachronous Gastric Neoplasm Prevention Following Endoscopic Submucosal Dissection for Gastric Adenoma
     Choong-Kyun Noh et al, 2023, JCM CrossRef
141. Helicobacter pylori and Human Immunodeficiency Virus Co-Infection: Potential Implications for Future Gastric Cancer Risk
     Marcel Nkuize et al, 2023, Microorganisms CrossRef
142. Helicobacter pylori-induced aberrant demethylation and expression of GNB4 promotes gastric carcinogenesis via the Hippo–YAP1 pathway
     Duanrui Liu et al, 2023, BMC Med CrossRef
143. Meta-analysis reveals Helicobacter pylori mutual exclusivity and reproducible gastric microbiome alterations during gastric carcinoma progression
     Yan Li et al, 2023, Gut Microbes CrossRef
144. Helicobacter pylori isolated from gastric juice have higher pathogenic potential than biopsy isolates
     Budhadev Baral et al, 2023, Genes & Diseases CrossRef
145. Helicobacter pylori Infection and Peptic Ulcer Disease in Symptomatic Children in Southern Vietnam: A Prospective Multicenter Study
     Tu Cam Nguyen et al, 2023, Healthcare CrossRef
146. Comprehensive insight into altered host cell-signaling cascades upon Helicobacter pylori and Epstein–Barr virus infections in cancer
     Dharmendra Kashyap et al, 2023, Arch Microbiol CrossRef
147. A novel therapeutic approach to prevent Helicobacter pylori induced gastric cancer using networking biology, molecular docking, and simulation approaches
     Nadeem Khan et al, 2023, Journal of Biomolecular Structure and Dynamics CrossRef
148. The Helicobacter pylori Genome Project: insights into H. pylori population structure from analysis of a worldwide collection of complete genomes
     Kaisa Thorell et al, 2023, Nat Commun CrossRef
149. Prevalence and temporal trend of gastric preneoplastic lesions in Asia: A systematic review with meta‐analysis
     Yunhao Li et al, 2023, UEG Journal CrossRef
150. Symbiotic microbial communities in various locations of the lung cancer respiratory tract along with potential host immunological processes affected
     Jiuling Cheng et al, 2024, Front. Cell. Infect. Microbiol. CrossRef
151. Primary Prevention of Gastric Cancer
     Nayoung Kim, 2023 CrossRef
152. Diagnostic Approaches to Helicobacter pylori: A Comparative Study of Detection in Gastric Biopsy and Aspirates
     Radha Kumari et al, 2024 CrossRef
153. A novel CRISPR/Cas12a biosensor for sensitive detection of Helicobacter pylori from clinical patients
     Luxin Yu et al, 2024, Sensors and Actuators B: Chemical CrossRef
154. Addressing Challenges in Standardizing Helicobacter pylori Treatment Protocols: Importance and Review
     Ranjot Kaur et al, 2024 CrossRef
155. A deep learning-driven discovery of berberine derivatives as novel antibacterial against multidrug-resistant Helicobacter pylori
     Xixi Guo et al, 2024, Sig Transduct Target Ther CrossRef
156. An Overview of Helicobacter pylori Survival Tactics in the Hostile Human Stomach Environment
     Yi Ying Cheok et al, 2021, Microorganisms CrossRef
157. Does a High Ratio of Dietary Omega-6/Omega-3 Fatty Acids Increase the Risk of Helicobacter pylori Infection? A Case-Control Study
     Masoumeh Khalighi Sikaroudi et al, 2024, Clin Nutr Res CrossRef
158. Common variants of vitamin D receptor gene polymorphisms and risk of gastric cancer: A meta-analysis
     Min Guan et al, 2024 CrossRef
159. The application of ginger supplementation on peptic ulcer disease management: A randomized, double blind, placebo-controlled clinical trial
     Hoda Arefpour et al, 2024, Clinical Nutrition Open Science CrossRef
160. The Trends of Gastric Cancer in China From 1990 to 2019 and Predictions to 2040: A Bayesian Age-Period-Cohort Prediction Study
     Hongyu Yang et al, 2024, Cancer Control CrossRef
161. Gastric cancer and associated pathogens: is there any association in Moroccan region?
     Samia Alaoui Boukhris et al, 2024, Jpn J Infect Dis CrossRef
162. Microbial composition of gastric lesions: differences based on Helicobacter pylori virulence profile
     Silvia Helena Barem Rabenhorst et al, 2024, Sci Rep CrossRef
163. Association of Hsa-mir-196 and Hsa-mir-153 Expression Levels With Gastric Cancer and H. pylori Infection
     Atefeh Moradi Nejad et al, 2024, Iran J Med Microbiol CrossRef
164. Can a diet rich in Brassicaceae help control Helicobacter pylori infection? A systematic review
     Sara Properzi et al, 2024, Front. Med. CrossRef
165. Recent advances in exploring new blood-based biomarkers for the early diagnosis of gastric cancer
     Xinyu Peng et al, 2025, Sci. China Chem. CrossRef
166. Metagenomic characterization of oral microbiome signatures to predict upper gastrointestinal and pancreaticobiliary cancers: a case–control study
     Sujin Oh et al, 2025, J Transl Med CrossRef